TY - JOUR
T1 - Low Atrial Fibrillatory Rate Is Associated with Poor Outcome in Patients with Mild to Moderate Heart Failure.
AU - Platonov, Pyotr
AU - Cygankiewicz, Iwona
AU - Stridh, Martin
AU - Holmqvist, Fredrik
AU - Vazquez, Rafael
AU - Bayes-Genis, Antoni
AU - McNitt, Scott
AU - Zareba, Wojciech
AU - Bayes de Luna, Antonio
PY - 2012
Y1 - 2012
N2 - BACKGROUND: -Atrial fibrillatory rate (AFR) is a measure of atrial remodeling caused by atrial fibrillation (AF) and its acceleration negatively affects outcome of interventions for persistent AF. However, the prognostic value of AFR in patients with CHF has not been studied. We sought to evaluate whether AFR can predict outcome in patients with mild to moderate (NYHA II-III) congestive heart failure (CHF). METHODS AND RESULTS: -High-resolution 20-min long Holter ECGs obtained from 169 CHF patients with AF at enrollment were analyzed. AFR was estimated using spatiotemporal QRST cancellation and time-frequency analysis. The patients were followed for a median of 44 months with primary endpoint defined as total mortality and secondary endpoints as sudden death and heart failure death. Atrial signal quality was sufficient for AFR estimation in 142 patients (mean age 69±11 years, 101 male). Of those, 48 patients died during follow-up, including 18 due to CHF progression. Mean AFR was 390±60 fpm and decreased with age (r=-0.3, p<0.001). Patients with AFR≤371 fpm (lower tertile) had 44% 3-year mortality as compared to 26% with higher AFR. Lower AFR was an independent predictor of all cause mortality (HR=1.99, 95% CI=1.09-3.63, p=0.025) and CHF death (HR=3.74, 95% CI=1.38-10.14, p=0.010) after adjustment for significant clinical covariates in multivariable Cox analysis. CONCLUSIONS: -In CHF patients with AF, reduced AFR assessed using non-invasive approach is associated with increased risk of death due to heart failure progression and may be considered as a predictor of outcome.
AB - BACKGROUND: -Atrial fibrillatory rate (AFR) is a measure of atrial remodeling caused by atrial fibrillation (AF) and its acceleration negatively affects outcome of interventions for persistent AF. However, the prognostic value of AFR in patients with CHF has not been studied. We sought to evaluate whether AFR can predict outcome in patients with mild to moderate (NYHA II-III) congestive heart failure (CHF). METHODS AND RESULTS: -High-resolution 20-min long Holter ECGs obtained from 169 CHF patients with AF at enrollment were analyzed. AFR was estimated using spatiotemporal QRST cancellation and time-frequency analysis. The patients were followed for a median of 44 months with primary endpoint defined as total mortality and secondary endpoints as sudden death and heart failure death. Atrial signal quality was sufficient for AFR estimation in 142 patients (mean age 69±11 years, 101 male). Of those, 48 patients died during follow-up, including 18 due to CHF progression. Mean AFR was 390±60 fpm and decreased with age (r=-0.3, p<0.001). Patients with AFR≤371 fpm (lower tertile) had 44% 3-year mortality as compared to 26% with higher AFR. Lower AFR was an independent predictor of all cause mortality (HR=1.99, 95% CI=1.09-3.63, p=0.025) and CHF death (HR=3.74, 95% CI=1.38-10.14, p=0.010) after adjustment for significant clinical covariates in multivariable Cox analysis. CONCLUSIONS: -In CHF patients with AF, reduced AFR assessed using non-invasive approach is associated with increased risk of death due to heart failure progression and may be considered as a predictor of outcome.
U2 - 10.1161/CIRCEP.111.964395
DO - 10.1161/CIRCEP.111.964395
M3 - Article
C2 - 22235036
SN - 1941-3084
VL - 5
SP - 77
EP - 83
JO - Circulation: Arrhythmia and Electrophysiology
JF - Circulation: Arrhythmia and Electrophysiology
IS - 1
ER -